Loading
Journal of Experimental Neurology
ISSN: 2692-2819
Most Cited Articles
Capillary Stalling: A Mechanism of Decreased Cerebral Blood Flow in AD/ADRD
Reece Crumpler, Richard J. Roman, Fan Fan
Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) are debilitating conditions that are highly associated with aging populations, especially those with comorbidities such as diabetes and hypertension.
J Exp Neurol, 2021, Volume 2, Issue 4, p149-153 | DOI: 10.33696/Neurol.2.048
Impact of Cellular Senescence on Neurodegenerative Diseases during the COVID-19 Pandemic: Suitable Targets Required to Eliminate Cellular Senescence
Md Mohiuddin, Kazuo Kasahara
We recently reviewed the scientific literature that elucidates the impact of cellular senescence on COVID-19 complications.
J Exp Neurol, 2021, Volume 2, Issue 3, p140-142 | DOI: 10.33696/Neurol.2.046
The Spread of Spectrin in Ataxia and Neurodegenerative Disease
Jon S. Morrow, Michael C. Stankewich
Experimental and hereditary defects in the ubiquitous scaffolding proteins of the spectrin gene family cause an array of neuropathologies
J Exp Neurol, 2021, Volume 2, Issue 3, p131-139 | DOI: 10.33696/Neurol.2.045
Stroke, Oxygen and Prehospital Care: A Commentary on Current Treatments and Opportunities for Improvement
John Collins, Igor Rybinnik, Bryan Fischberg, Jonathan McCoy
Stroke is a common and very serious illness where timely evaluation and intervention can have dramatic effects on patient outcomes.
J Exp Neurol, 2021, Volume 2, Issue 1, p39-46 | DOI: 10.33696/Neurol.2.034
Commentary on Vulnerability and Resilience to Activity- Based Anorexia and the Role of Dopamine
Jeff A. Beeler, Nesha S. Burghardt
Anorexia nervosa (AN) is an eating disorder characterized by a fear of gaining weight and self-starvation, leading to life-threatening weight loss [1]. It occurs predominately in women and frequently begins during adolescence.
J Exp Neurol, 2021, Volume 2, Issue 1, p21-28 | DOI: 10.33696/Neurol.2.031
Cathepsin D: A Candidate Link between Amyloid β-protein and Tauopathy in Alzheimer Disease
Caitlin N. Suire, Malcolm A. Leissring
Alzheimer disease (AD) is a debilitating neurodegenerative disorder characterized by extracellular deposition of the amyloid β-protein (Aβ) and intraneuronal accumulation of the microtubule-associated protein, tau
J Exp Neurol, 2021, Volume 2, Issue 1, p10-15 | DOI: 10.33696/Neurol.2.029
Alzheimers Disease: A Brief Review
Samantha McGirr, Courtney Venegas, Arun Swaminathan
The worldwide prevalence of dementia is estimated to be over 45 million people. Alzheimer’s disease (AD) is the most common cause of dementia, responsible for 60-80% of cases.
J Exp Neurol, 2020, Volume 1, Issue 3, p89-98 | DOI: 10.33696/Neurol.1.015